These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21029471)

  • 1. Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study.
    Solís-Ortiz S; Pérez-Luque E; Morado-Crespo L; Gutiérrez-Muñoz M
    Behav Brain Funct; 2010 Oct; 6():67. PubMed ID: 21029471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
    Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
    PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the functional Catechol-O-Methyltranferase (COMT) Val
    Khanthiyong B; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
    Int J Med Sci; 2019; 16(11):1461-1465. PubMed ID: 31673237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transcranial direct current stimulation (tDCS) on executive functions: influence of COMT Val/Met polymorphism.
    Plewnia C; Zwissler B; Längst I; Maurer B; Giel K; Krüger R
    Cortex; 2013; 49(7):1801-7. PubMed ID: 23237479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.
    Cherner M; Watson CW; Saloner R; Halpin LE; Minassian A; Murray SS; Vaida F; Bousman C; Everall I;
    Addict Behav; 2019 Nov; 98():106023. PubMed ID: 31301644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.
    Verdejo-García A; Fagundo AB; Cuenca A; Rodriguez J; Cuyás E; Langohr K; de Sola Llopis S; Civit E; Farré M; Peña-Casanova J; de la Torre R
    Neuropsychopharmacology; 2013 Jul; 38(8):1598-606. PubMed ID: 23449176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of a functional catechol-o-methyltransferase polymorphism and cognitive function in patients with dementia.
    Nedić G; Borovecki F; Klepac N; Mubrin Z; Hajnsek S; Nikolac M; Muck-Seler D; Pivac N
    Coll Antropol; 2011 Jan; 35 Suppl 1():79-84. PubMed ID: 21648315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
    Nkam I; Ramoz N; Breton F; Mallet J; Gorwood P; Dubertret C
    PLoS One; 2017; 12(1):e0170147. PubMed ID: 28085950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.
    Ji W; Li N; Ju K; Zheng H; Yang C; Xu P; Chen S; Cao A; Chen X; Guo L
    Neurol Sci; 2015 Apr; 36(4):561-70. PubMed ID: 25367405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
    Bilder RM; Volavka J; Czobor P; Malhotra AK; Kennedy JL; Ni X; Goldman RS; Hoptman MJ; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Kunz M; Chakos M; Cooper TB; Lieberman JA
    Biol Psychiatry; 2002 Oct; 52(7):701-7. PubMed ID: 12372660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
    de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
    J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine.
    Hamidovic A; Dlugos A; Palmer AA; de Wit H
    Psychiatr Genet; 2010 Jun; 20(3):85-92. PubMed ID: 20414144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition.
    Bosia M; Buonocore M; Bechi M; Stere LM; Silvestri MP; Inguscio E; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():363-368. PubMed ID: 30790675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study.
    Wu K; O'Keeffe D; Politis M; O'Keeffe GC; Robbins TW; Bose SK; Brooks DJ; Piccini P; Barker RA
    Brain; 2012 Aug; 135(Pt 8):2449-57. PubMed ID: 22843413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the catechol-O-methyltransferase (COMT) Val158Met polymorphism and manual aiming control in healthy subjects.
    Lage GM; Miranda DM; Romano-Silva MA; Campos SB; Albuquerque MR; Corrêa H; Malloy-Diniz LF
    PLoS One; 2014; 9(6):e99698. PubMed ID: 24956262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men.
    Smyrnis N; Avramopoulos D; Evdokimidis I; Stefanis CN; Tsekou H; Stefanis NC
    Biol Psychiatry; 2007 Apr; 61(7):845-53. PubMed ID: 17123481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.